76 related articles for article (PubMed ID: 7654031)
1. Sensitization of human glioblastoma T98G cells to VP16 and VM26 by human tumor necrosis factor.
Morgavi P; Cimoli G; Ottoboni C; Michelotti A; Conte P; Parodi S; Russo P
Anticancer Res; 1995; 15(4):1423-8. PubMed ID: 7654031
[TBL] [Abstract][Full Text] [Related]
2. DNA breakage in human lung carcinoma cells and nuclei that are naturally sensitive or resistant to etoposide and teniposide.
Long BH; Musial ST; Brattain MG
Cancer Res; 1986 Aug; 46(8):3809-16. PubMed ID: 3015377
[TBL] [Abstract][Full Text] [Related]
3. [Antiproliferative effect of tumor necrosis factor-alpha on human glioblastoma cells].
Kato T
Hokkaido Igaku Zasshi; 1995 Mar; 70(2):261-74. PubMed ID: 7774879
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxicity mediated by tumor necrosis factor in variant subclones of the ME-180 cervical carcinoma line: modulation by specific inhibitors of DNA topoisomerase II.
Coffman FD; Green LM; Godwin A; Ware CF
J Cell Biochem; 1989 Feb; 39(2):95-105. PubMed ID: 2541144
[TBL] [Abstract][Full Text] [Related]
5. Anti-invasive effect of contortrostatin, a snake venom disintegrin, and TNF-alpha on malignant glioma cells.
Schmitmeier S; Markland FS; Chen TC
Anticancer Res; 2000; 20(6B):4227-33. PubMed ID: 11205252
[TBL] [Abstract][Full Text] [Related]
6. Single- and double-strand DNA breakage and repair in human lung adenocarcinoma cells exposed to etoposide and teniposide.
Long BH; Musial ST; Brattain MG
Cancer Res; 1985 Jul; 45(7):3106-12. PubMed ID: 3839166
[TBL] [Abstract][Full Text] [Related]
7. Increased death receptor 5 expression by chemotherapeutic agents in human gliomas causes synergistic cytotoxicity with tumor necrosis factor-related apoptosis-inducing ligand in vitro and in vivo.
Nagane M; Pan G; Weddle JJ; Dixit VM; Cavenee WK; Huang HJ
Cancer Res; 2000 Feb; 60(4):847-53. PubMed ID: 10706092
[TBL] [Abstract][Full Text] [Related]
8. Establishment of persistent infection with HIV-1 abrogates the caspase-3-dependent apoptotic signaling pathway in U937 cells.
Tanaka Y; Kameoka M; Ota K; Itaya A; Ikuta K; Yoshihara K
Exp Cell Res; 1999 Mar; 247(2):514-24. PubMed ID: 10066379
[TBL] [Abstract][Full Text] [Related]
9. IFN-beta inhibition of etoposide resistance acquisition in vitro: studies using a human glioblastoma cell line.
Ishihara H; Kajiwara K; Ohshita N; Kimura Y; Nishizaki T; Ito H
Anticancer Res; 1995; 15(2):283-7. PubMed ID: 7762995
[TBL] [Abstract][Full Text] [Related]
10. Adriamycin sensitizes the adriamycin-resistant 8226/Dox40 human multiple myeloma cells to Apo2L/tumor necrosis factor-related apoptosis-inducing ligand-mediated (TRAIL) apoptosis.
Jazirehi AR; Ng CP; Gan XH; Schiller G; Bonavida B
Clin Cancer Res; 2001 Dec; 7(12):3874-83. PubMed ID: 11751478
[TBL] [Abstract][Full Text] [Related]
11. Sensitization of tumor cells to tumor necrosis factor action by the protein kinase inhibitor staurosporine.
Beyaert R; Vanhaesebroeck B; Heyninck K; Boone E; De Valck D; Schulze-Osthoff K; Haegeman G; Van Roy F; Fiers W
Cancer Res; 1993 Jun; 53(11):2623-30. PubMed ID: 8495426
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia increases endothelin-1 mRNA expression but not immunoreactive endothelin in the medium of T98G glioblastoma cells under cytokine treatment.
Zhang Y; Li Y; Totsune K; Kikuchi K; Murakami O; Shibahara S; Takahashi K
Peptides; 2006 Nov; 27(11):3003-6. PubMed ID: 16720059
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of multidrug resistance protein gene in human cancer cell lines selected for drug resistance to epipodophyllotoxins.
Koike K; Abe T; Hisano T; Kubo T; Wada M; Kohno K; Kuwano M
Jpn J Cancer Res; 1996 Jul; 87(7):765-72. PubMed ID: 8698628
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of nuclear factor-kappaB activation confers sensitivity to tumor necrosis factor-alpha by impairment of cell cycle progression in human glioma cells.
Otsuka G; Nagaya T; Saito K; Mizuno M; Yoshida J; Seo H
Cancer Res; 1999 Sep; 59(17):4446-52. PubMed ID: 10485496
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity of drug-resistant human ovarian tumor cell lines to combined effects of tumor necrosis factor (TNF-alpha) and doxorubicin: failure of the combination to modulate the MDR phenotype.
Safrit JT; Berek JS; Bonavida B
Gynecol Oncol; 1993 Feb; 48(2):214-20. PubMed ID: 8428693
[TBL] [Abstract][Full Text] [Related]
16. Differences in susceptibility to tumor necrosis factor alpha-induced apoptosis among MCF-7 breast cancer cell variants.
Burow ME; Weldon CB; Tang Y; Navar GL; Krajewski S; Reed JC; Hammond TG; Clejan S; Beckman BS
Cancer Res; 1998 Nov; 58(21):4940-6. PubMed ID: 9810003
[TBL] [Abstract][Full Text] [Related]
17. Effect of cell cycle on the regulation of the cell surface and secreted forms of type I and type II human tumor necrosis factor receptors.
Pocsik E; Mihalik R; Penzes M; Loetscher H; Gallati H; Aggarwal BB
J Cell Biochem; 1995 Nov; 59(3):303-16. PubMed ID: 8567749
[TBL] [Abstract][Full Text] [Related]
18. Triple helix-forming oligodeoxyribonucleotides targeted to the human tumor necrosis factor (TNF) gene inhibit TNF production and block the TNF-dependent growth of human glioblastoma tumor cells.
Aggarwal BB; Schwarz L; Hogan ME; Rando RF
Cancer Res; 1996 Nov; 56(22):5156-64. PubMed ID: 8912851
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor alpha as an autocrine and paracrine growth factor for ovarian cancer: monokine induction of tumor cell proliferation and tumor necrosis factor alpha expression.
Wu S; Boyer CM; Whitaker RS; Berchuck A; Wiener JR; Weinberg JB; Bast RC
Cancer Res; 1993 Apr; 53(8):1939-44. PubMed ID: 8385577
[TBL] [Abstract][Full Text] [Related]
20. Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide resistance.
Schneider E; Horton JK; Yang CH; Nakagawa M; Cowan KH
Cancer Res; 1994 Jan; 54(1):152-8. PubMed ID: 7903202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
